| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Ulcerative Colitis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Colitis | |||||
| Colitis, Ulcerative | |||||
| Ulcer | |||||
| 3 | More general conditions related to this trial | ||||
| Colonic Diseases | |||||
| Digestive System Diseases | |||||
| Gastroenteritis | |||||
| Gastrointestinal Diseases | |||||
| Inflammatory Bowel Diseases | |||||
| Intestinal Diseases | |||||
| Pathologic Processes | |||||
| 4 | Interventions listed in this trial | ||||
| Rituximab | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antineoplastic Agents | |||||
| Antirheumatic Agents | |||||
| Immunologic Factors | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Royal Liverpool University Hospital | |||||
| Hoffmann-La Roche | |||||
|
